Federal contractor · LAWRENCE, KS

DESIGN-ZYME LLC

No contract obligations recorded for DESIGN-ZYME LLC in FY2026. Since FY2017: $3M. Its largest customer was National Institutes of Health ($0).

Obligations · FY2026
$0
New awards
1
Sole-source
—
Single offer
—
UEI
RM33XDX5RRG4
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 0FY2017
  2. 0FY2018
  3. 3MFY2024
  4. 0FY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$00.0%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. DEVELOPMENT OF COVALENTLY BOUND HYALURONIC ACID AS AN ADJUVANT FOR MULTIVALENT LYME DISEASE VACCINE$3M
    National Institutes of Health· Douglas County, KS· Research & development· Sep 18, 2024 – Jul 17, 2026· 75N93024C00016

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

DESIGN-ZYME LLC received $0 in federal assistance in FY2026, on 0 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
0

Assistance by fiscal year

  1. 0FY2022

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2022.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. ADJUVAX LLC$3M−100% in FY2026
    HOOVER, AL · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. CONTINUITY BIOSCIENCES, LLC$3M−100% in FY2026
    BRADENTON, FL · 99.9% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. NOVOMEDIX LLC$3M−100% in FY2026
    SAN DIEGO, CA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.